117 related articles for article (PubMed ID: 2439812)
1. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
Grevel J
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
[TBL] [Abstract][Full Text] [Related]
3. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
Ishibashi T; Mitomi A; Tatebe S; Imai S
Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
5. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
Harron DW; Goa KL; Langtry HD
Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
[TBL] [Abstract][Full Text] [Related]
6. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Schiess W; Dorow P
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S30-3. PubMed ID: 2439815
[TBL] [Abstract][Full Text] [Related]
7. The antihypertensive effect of atenolol and bopindolol in the elderly.
Viskoper RJ; Laszt A; Oren S; Hochberg Y; Villa Y; Drexler I; Bregman L; Mishal J
Neth J Med; 1989 Oct; 35(3-4):185-91. PubMed ID: 2574832
[TBL] [Abstract][Full Text] [Related]
8. Bopindolol: a slowly dissociating antagonist from the beta-adrenoceptors in guinea pig atria.
Hosohata Y; Hattori K; Shen Y; Okuyama M; Kaneko H; Ohnuki T; Suzuki J; Nagatomo T
Pharmacology; 1998 Oct; 57(4):180-7. PubMed ID: 9730775
[TBL] [Abstract][Full Text] [Related]
9. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
Kirch W; Axthelm T
Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of once-daily bopindolol and atenolol for mild-to-moderate hypertension.
Colnago R; Meregalli M; Turri D; Nazzari M; Fiorella G; Guffanti EE; Mazzola C
Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):347-52. PubMed ID: 2887520
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic oral administration of a new beta-blocker, bopindolol, on serum lipoprotein concentrations and blood pressure of spontaneously hypertensive rats.
Ishihara T; Chin WP; Yoshida Y; Sun HT; Mitomi A; Ishibashi T; Tamura K; Imai S
Arch Int Pharmacodyn Ther; 1989; 302():145-57. PubMed ID: 2576891
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol.
Aellig WH
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S12-5. PubMed ID: 2439811
[TBL] [Abstract][Full Text] [Related]
13. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
[TBL] [Abstract][Full Text] [Related]
14. Interindividual pharmacokinetic and pharmacodynamic variability of different beta blockers.
Dayer P; Mérier G; Perrenoud JJ; Marmy A; Leemann T
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S20-4. PubMed ID: 2439813
[TBL] [Abstract][Full Text] [Related]
15. Sustaining effects of bopindolol on inhibitory chronotropic actions in guinea pig atria.
Hattori K; Suzuki J; Hosohata Y; Ohnuki T; Nakamura T; Watanabe K; Muramatsu I; Nagatomo T
Pharmacology; 1999 Oct; 59(4):183-91. PubMed ID: 10474078
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.
Wellstein A; Palm D; Belz GG; Pitschner HF
Arzneimittelforschung; 1985; 35(1):2-6. PubMed ID: 2859024
[TBL] [Abstract][Full Text] [Related]
17. Acute and long-term antihypertensive effect of bopindolol--a nonselective beta-adrenergic blocker with ISA.
Andersson OK; Hedner T; Nyberg G
Eur J Clin Pharmacol; 1985; 29(3):281-5. PubMed ID: 2866965
[TBL] [Abstract][Full Text] [Related]
18. Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Dorow P; Schiess W
Klin Wochenschr; 1986 Apr; 64(8):366-9. PubMed ID: 2871220
[TBL] [Abstract][Full Text] [Related]
19. Dose-finding study with bopindolol in arterial hypertension.
Willimann P; Peter R; Siegenthaler H
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S25-9. PubMed ID: 2439814
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamic effects of atenolol and bopindolol at rest and during isometric exercise. A non-invasive study in healthy volunteers.
Nieminen MS; Rapola J; Pellinen TJ; Toivonen L
Ann Clin Res; 1988; 20(6):431-5. PubMed ID: 2905879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
